2008
- Staner L, Graff C, Luthringer R, Noel N. Effect of selective activation of 5-HT3 receptors on sleep and waking. In, Monti J. M , Pandi-Perumal S. R., Jacobs B.L., Nutt D.J., (eds.), Serotonin and Sleep : Molecular, Functional and Clinical Aspects. Birkhauser Verlag, Basel, 2008. pp 415-438.
- Staner L, Noël N, Luthringer R. Schizophrenia, sleep, and antipsychotic drugs. In Pandi-Perumal SR , Verster J , Monti J, Langer S. Sleep disorders: diagnosis and therapeutics, Informa Healthcare, pp 417-426.
2007
- Muzet A. Sleeping environments: their impact on public health. In Pandi-Perumal SR, Leger D. Sleep and public health, Taylor & Francis, 2007.
- Finegold LS, Muzet A, Berry BF. Sleep disturbance due to transportation noise exposure. In Handbook of Noise and Vibration Control, Crocker MJ (ed), John Wiley & Sons, Hoboken, New Jersey, 2007. pp. 308-315.
2006
- Staner L, Luthringer R, Le Bon O. Sleep disturbances in affective disorders. In Pandi-Perumal SR., Monti JM (eds.). Clinical Pharmacology of Sleep, Basel, Birkhauser Verlag , 2006. pp 101-124.
- Muzet A. Vigilance et sécurité. In Bimes-Arbus S., Lazorthes Y., Rougé D. et al. Sciences Humaines et Sociales, Abrégés PCEM1, Paris, Masson, 2006. pp 447-452.
2005
- Staner L, Monreal J, Correa H, Tremeau F, Stefos G. Axis I and axis II characterisation of inpatients with impulse control dysregulation. In Morgan JP (ed). Psychology of Aggression, New York : Nova Science, 2005 : pp 187-202.
2004
- Boeijinga P. Psychometrics, behaviour and EEG. In Essentials and applications of EEG research in preclinical and clinical pharmacology. Drinkenburg WH, Ruigt GS, Jobert M. Berlin: IPEG, 2004: 175-201.
- Boeijinga P. Interaction "protéo-réceptomics" du système nerveux central et transmission macroscopique en neuropharmacologie. In Imagerie et photonique pour les Sciences du vivant et la médecine. Faupel M, Smigielski P, Grzymala R. Lausanne: FontisMedia, 2004: 93-108.
2003
- Duval F. Endocrinologie et psychiatrie. In Encycl Med Chir 2003; 37(640 A10):1-28.
- Gilles C. Psychogériatrie. In Dierick M, Ansseau M, D'Haenen H, Peuskens J, Linkowski P. Manuel de psychopharmacothérapie. 2ème éd. Gent: Academia Press, 2003: 479-507.
- Boeijinga PH, Nedelec JF, Demazières A, Souan ML, Gamand S, Parot P, Luthringer R, Macher JP. Characterization of the CNS effects of naftidrofuryl (PRAXILENE) : A quantitative EEG and functional MRI, placebo controlled stuudy in healthy elderly subjects. In Amos D Korczyn (Eds). Proceedings Third International Congress of Vascular Dementia. Bologna : Monduzzi eds, 2003 : 171-176.
